REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
ACTALIVE BIOTHERAPEUTIC PRODUCTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/06/2026
Classification
Registered
Trademark type
Combined
Nice classes
40, 42
Filing date
05/22/2020
Registration date
07/06/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2020
First use in commerce
09/01/2020
Drawing code
5
Owner type
16
Owner location
Watertown, MA, US
Examiner
SNABB, SANDRA MARIE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ACTALIVE" in larger stylized font above the words "BIOTHERAPEUTIC PRODUCTS" in smaller font.
Holders and representatives
Holders
Arranta Bio Holdings, LLC
Representatives
Jessica L. Rothstein Goodwin Procter LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; treatment of materials, namely, pharmaceutical, biologic, and chemical products and their components used in the manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals; manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products and reagents
Class 42
Research and development of pharmaceutical products, biopharmaceutical products, biotherapeutic products, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/03/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/02/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/15/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/15/2021
IUAF
USE AMENDMENT FILED
05/05/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/05/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/19/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/19/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/06/2020
PUBO
PUBLISHED FOR OPPOSITION
10/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/16/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
08/28/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/28/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
08/28/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/28/2020
DOCK
ASSIGNED TO EXAMINER
08/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2020
NWAP
NEW APPLICATION ENTERED
05/26/2020
Continuous trademark protection
Get notified about every new filing that threatens ACTALIVE BIOTHERAPEUTIC PRODUCTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.